Use of denosumab in osteogenesis imperfecta: A case report

Article

Abstract: Osteogenesis imperfecta (OI) is an inherited disorder of phenotypically heterogeneous affections of

Palabras claves:

Denosumab, fractures, heterogeneity, Osteogenesis imperfecta

Autores:

Christian Ferro, Maldonado G., Paredes C., Rios C.

Fuentes:

scopus